These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 21116871)

  • 1. Transplantation of hematopoietic stem cells in human severe combined immunodeficiency: longterm outcomes.
    Buckley RH
    Immunol Res; 2011 Apr; 49(1-3):25-43. PubMed ID: 21116871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hematopoietic stem-cell transplantation for the treatment of severe combined immunodeficiency.
    Buckley RH; Schiff SE; Schiff RI; Markert L; Williams LW; Roberts JL; Myers LA; Ward FE
    N Engl J Med; 1999 Feb; 340(7):508-16. PubMed ID: 10021471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Haploidentical bone marrow stem cell transplantation in human severe combined immunodeficiency.
    Buckley RH; Schiff SE; Schiff RI; Roberts JL; Markert ML; Peters W; Williams LW; Ward FE
    Semin Hematol; 1993 Oct; 30(4 Suppl 4):92-101; discussion 102-4. PubMed ID: 7905667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hematopoietic stem cell transplantation for severe combined immunodeficiency in the neonatal period leads to superior thymic output and improved survival.
    Myers LA; Patel DD; Puck JM; Buckley RH
    Blood; 2002 Feb; 99(3):872-8. PubMed ID: 11806989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of severe combined immunodeficiency phenotype on the outcome of HLA non-identical, T-cell-depleted bone marrow transplantation: a retrospective European survey from the European group for bone marrow transplantation and the european society for immunodeficiency.
    Bertrand Y; Landais P; Friedrich W; Gerritsen B; Morgan G; Fasth A; Cavazzana-Calvo M; Porta F; Cant A; Espanol T; Müller S; Veys P; Vossen J; Haddad E; Fischer A
    J Pediatr; 1999 Jun; 134(6):740-8. PubMed ID: 10356144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current Knowledge and Priorities for Future Research in Late Effects after Hematopoietic Stem Cell Transplantation (HCT) for Severe Combined Immunodeficiency Patients: A Consensus Statement from the Second Pediatric Blood and Marrow Transplant Consortium International Conference on Late Effects after Pediatric HCT.
    Heimall J; Puck J; Buckley R; Fleisher TA; Gennery AR; Neven B; Slatter M; Haddad E; Notarangelo LD; Baker KS; Dietz AC; Duncan C; Pulsipher MA; Cowan MJ
    Biol Blood Marrow Transplant; 2017 Mar; 23(3):379-387. PubMed ID: 28068510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term immune reconstitution and outcome after HLA-nonidentical T-cell-depleted bone marrow transplantation for severe combined immunodeficiency: a European retrospective study of 116 patients.
    Haddad E; Landais P; Friedrich W; Gerritsen B; Cavazzana-Calvo M; Morgan G; Bertrand Y; Fasth A; Porta F; Cant A; Espanol T; Müller S; Veys P; Vossen J; Fischer A
    Blood; 1998 May; 91(10):3646-53. PubMed ID: 9573000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Matched unrelated bone marrow transplant for severe combined immunodeficiency.
    Roifman CM; Grunebaum E; Dalal I; Notarangelo L
    Immunol Res; 2007; 38(1-3):191-200. PubMed ID: 17917025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinetics of T-cell development of umbilical cord blood transplantation in severe T-cell immunodeficiency disorders.
    Knutsen AP; Wall DA
    J Allergy Clin Immunol; 1999 May; 103(5 Pt 1):823-32. PubMed ID: 10329816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Positive Family History, Infection, Low Absolute Lymphocyte Count (ALC), and Absent Thymic Shadow: Diagnostic Clues for All Molecular Forms of Severe Combined Immunodeficiency (SCID).
    McWilliams LM; Dell Railey M; Buckley RH
    J Allergy Clin Immunol Pract; 2015; 3(4):585-91. PubMed ID: 25824440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transplantation of X-linked severe combined immunodeficient dogs with CD34+ bone marrow cells.
    Hartnett BJ; Yao D; Suter SE; Ellinwood NM; Henthorn PS; Moore PE; McSweeney PA; Nash RA; Brown JD; Weinberg KI; Felsburg PJ
    Biol Blood Marrow Transplant; 2002; 8(4):188-97. PubMed ID: 12014808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of natural killer cell killer Ig-like receptor alloreactivity on the outcome of bone marrow stem cell transplantation for severe combined immunodeficiency (SCID).
    Keller MD; Chen DF; Condron SA; Liu N; Reinsmoen NL; Buckley RH
    J Clin Immunol; 2007 Jan; 27(1):109-16. PubMed ID: 17191149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-Term Clinical Outcomes of Severe Combined Immunodeficiency Patients Given Nonablative Marrow Transplants.
    Hardin O; Lokhnygina Y; Buckley RH
    J Allergy Clin Immunol Pract; 2022 Apr; 10(4):1077-1083. PubMed ID: 34942385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for engraftment of donor-type multipotent CD34+ cells in a patient with selective T-lymphocyte reconstitution after bone marrow transplantation for B-SCID.
    Tjønnfjord GE; Steen R; Veiby OP; Friedrich W; Egeland T
    Blood; 1994 Nov; 84(10):3584-9. PubMed ID: 7524743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multilineage hematopoietic engraftment after allogeneic peripheral blood stem cell transplantation without conditioning in SCID patients.
    Bielorai B; Trakhtenbrot L; Amariglio N; Rothman R; Tabori U; Dallal I; Golan H; Neumann Y; Reichart M; Kaplinsky C; Rechavi G; Toren A
    Bone Marrow Transplant; 2004 Aug; 34(4):317-20. PubMed ID: 15220954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of multiple monoclonal serum immunoglobulins (multiclonal gammopathy) following both HLA-identical unfractionated and T cell-depleted haploidentical bone marrow transplantation in severe combined immunodeficiency.
    Kent EF; Crawford J; Cohen HJ; Buckley RH
    J Clin Immunol; 1990 Mar; 10(2):106-14. PubMed ID: 2338452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of reduced intensity conditioning in T-cell and B-cell immune reconstitution after HLA-identical bone marrow transplantation in ADA-SCID.
    Cancrini C; Ferrua F; Scarselli A; Brigida I; Romiti ML; Barera G; Finocchi A; Roncarolo MG; Caniglia M; Aiuti A
    Haematologica; 2010 Oct; 95(10):1778-82. PubMed ID: 20460637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reconstitution of T- and B-cell function after T-lymphocyte-depleted haploidentical bone marrow transplantation in severe combined immunodeficiency due to adenosine deaminase deficiency.
    Silber GM; Winkelstein JA; Moen RC; Horowitz SD; Trigg M; Hong R
    Clin Immunol Immunopathol; 1987 Sep; 44(3):317-20. PubMed ID: 3304740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thymic function after hematopoietic stem-cell transplantation for the treatment of severe combined immunodeficiency.
    Patel DD; Gooding ME; Parrott RE; Curtis KM; Haynes BF; Buckley RH
    N Engl J Med; 2000 May; 342(18):1325-32. PubMed ID: 10793165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The kinetics of early T and B cell immune recovery after bone marrow transplantation in RAG-2-deficient SCID patients.
    Lev A; Simon AJ; Bareket M; Bielorai B; Hutt D; Amariglio N; Rechavi G; Somech R
    PLoS One; 2012; 7(1):e30494. PubMed ID: 22295088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.